Hélène SapinFollowEli Lilly (United States)1 paperORCID 0000-0003-2602-8450 ↗OpenAlex ↗PapersInternational Journal of ObesityIn silico·29 SepIndirect comparative efficacy and safety of tirzepatide vs semaglutide for the treatment of obesity or overweight in patients without type 2 diabetes
International Journal of ObesityIn silico·29 SepIndirect comparative efficacy and safety of tirzepatide vs semaglutide for the treatment of obesity or overweight in patients without type 2 diabetes